Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (889257)	9/21/2015 10:51:51 AM
From: bentway	Respond to of 1577020

I don't KNOW, Dave. But YOU claim to, with ideology but no evidence.

To: i-node who wrote (889257)	9/22/2015 2:00:09 PM
From: combjelly	Read Replies (2) \| Respond to of 1577020

Evidently, something is getting in the way of normal market processes. What you do you think that might be? He is gaming the system. Nothing to do with Obamacare at all. So there’s already been one round of price-jacking with this old drug, and now Turing is here to take it to unheard-of levels. In any functioning market, someone else would jump in and offer this compound for less – but Turing’s business plan includes “closed distribution”, that loophole mentioned above to try to keep any other generic companies from getting enough of the drug to run a clinic trial proving equivalence. blogs.sciencemag.org